Skip to search formSkip to main contentSkip to account menu

marbofloxacin

Known as: 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol(3,2,1-ij)(4,2,1)benzoxadiazin-6 carboxylic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The pharmacokinetic behavior of marbofloxacin was studied in healthy (n = 12) and Pasteurella multocida infected rabbits (n = 12… 
2003
2003
OBJECTIVE To evaluate, by use of population pharmacokinetics, the disposition of marbofloxacin in the aqueous humor after IV… 
2003
2003
The Pasteurella multocida infection was induced by the intramuscular inoculation with 3×105 colonyforming units per kg body… 
Highly Cited
2002
Highly Cited
2002
The pharmacokinetic behavior of marbofloxacin was studied in goats after single-dose intravenous (i.v.) and intramuscular (i.m… 
2001
2001
A multicentre, controlled, randomized and blinded trial was carried out in 180 ruminating calves with pyrexia and respiratory… 
2000
2000
Summary In a controlled and randomized field trial carried out in three European countries, 219 fattening pigs, from seven farms… 
1999
1999
Thirty-nine dogs with severe and/or recurrent lesions of pyoderma were treated with marbofloxacin at an average dosage of 2.12 mg… 
Highly Cited
1998
Highly Cited
1998
The multi-residue procedure for basic drugs described elsewhere by this laboratory has been evaluated for quinolone and…